Clinical Trial Update: Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial of the probiotic GanedenBC30 for major depressive disorder and irritable bowel syndrome was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Major Depressive Disorder

Drugs mentioned

• GanedenBC30 (Bacillus coagulans GBI-30, 6086)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Irritable Bowel Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2013-08-09